Do women with diabetes receive hormone replacement therapy?

Practical Diabetes International

Volumn 15, Issue 3, 1998, Pages 71-72

  Lawrenson, R A ^a   Newson, R B ^a   Feher, M D ^a  

^a Surrey Research Park   (United Kingdom)

Author keywords

Diabetes mellitus; Hormone replacement therapy (HRT); Prescribing rates

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CORONARY RISK; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION;

EID: 0031814780     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.1960150305     Document Type: Article

References (18)

1. 1 Zimmet PZ, Alberti KGMM. The changing face of macrovascular disease in non‐insulin‐dependent diabetes mellitus: an epidemic in progress. Lance: 1997 ; 350 (suppl): 1–4
2. 2 Grodstein F, Stampfer MJ, Manson J, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996 ; 335 (7): 453–61
3. 3 Beard Cm, Kottke Te, Annegers Jf, Ballard Dj. The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40‐to‐59‐year‐old women, 1960 through 1982. Mayo Clin Proc 1989 ; 64: 471–80
4. 4 Manson Je, Ridker Pm, Gaziano Jm, Henekens Ch. Prevention of Myocardial Infarction. Oxford, UK: Oxford University Press, p 244
5. 5 Rai H. Data catalogue. First edition. London: IMS Global Services, 1995 ; 18–30
6. 6 Pringle M, Ward P, Chilvers C. Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer. Br J Gen Pract 1995 ; 45: 37–41
7. 7 Morris AD, Boyle DL, McAlpine R, et al. The diabetes audit and research in Tayside Scotland (DARTS) study: an electronic record linkage to create a diabetes register. BMJ 1997 ; 315: 524–8
8. 8 Sinclair Hk, Bond Cm, Taylor Rj. Hormone replacement therapy: a study of women's knowledge and attitudes. Br J Gen Pract 1993 ; 43: 65–70
9. 9 Spector Td. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. BMJ 1989 ; 299: 1434–35
10. 10 Mann Rd, Chukwujindu Ylj, Chanter Do. A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women. J Clin Epidemio 1994 ; 47: 307–12
11. 11 Lancaster T, Surman G, Lawrence M, et al. Hormone replacement therapy: characteristics of users and non‐users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Community Health 1995 ; 49: 389–94
12. 12 Feher Md, Isaacs Aj. Is hormone replacement therapy prescribed for postmenopausal diabetic women? Br J Clin Path 1996 ; 50: 431–32
13. 13 Banks E. English R, Richardson A. Woman doctor's use of hormone replacement therapy. (Letter). BMJ 312: 638
14. 14 Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ 1995 ; 11 1399–401
15. 15 Wilkes Hc, Meade Tw. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ 1991 ; 302: 1317–20
16. 16 Feher MD, Cox A, Levy A, et al. Short‐term blood pressure and metabolic effects of tibolone in postmenopausal women with non‐insulin dependent diabetes. Br J Obstet Gynaecol 1996 ; 103: 281–83
17. 17. Gaball Goodman‐Gruen D, Barett‐Connor E. The effect of postmenopausal estrogen therapy on the risk of non‐insulin‐dependent diabetes mellitus. Am J Public Health 1997 ; 87: 1–3
18. 18 Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic overview. Diabetes Metab Review 1987 ; 3 (2): 463–524